Ligandal
4 known investors
Ligandal develops precision medicine targeting technology, including its Peptide Direct Conjugate (PDC) platform driven by LigandAI and Predictive Interactomics, to guide therapeutics to specific disease sites at the molecular level. The company positions its technology as an enabling delivery layer for next-generation, molecularly and genomically precise therapeutics.
Founders & leadership
AW
Investors · 4
In the news
Frequently asked questions
- What does Ligandal do?
- Ligandal develops precision medicine targeting technology, including its Peptide Direct Conjugate (PDC) platform driven by LigandAI and Predictive Interactomics, to guide therapeutics to specific disease sites at the molecular level. The company positions its technology as an enabling delivery layer for next-generation, molecularly and genomically precise therapeutics.
- Who founded Ligandal?
- Ligandal was founded by Andre Watson.
- Who are Ligandal's investors?
- Ligandal's investors include Flucas Ventures, Hemisphere Ventures LLC, Machina Ventures, Sommet AB.